<DOC>
	<DOCNO>NCT01675557</DOCNO>
	<brief_summary>The purpose study compare pharmacokinetic 25 ( OH ) D 1,25 ( OH ) 2D response single oral dose vitamin D2 vitamin D3 group Stage 5-Chronic Kidney Disease subject require chronic hemodialysis .</brief_summary>
	<brief_title>Pharmacokinetic Comparison Vitamin 's D2 D3 Stage 5 Chronic Kidney Disease Patients Chronic Hemodialysis</brief_title>
	<detailed_description>This randomize , single blind , control study . Subjects randomly assign receive 1 ) placebo capsule ( control group ) ; 2 ) capsule ergocalciferol ( vitamin D2 group ) ; 3 ) capsule cholecalciferol ( vitamin D3 group ) .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>30 men woman , age 2065 , BMI 1830 , require chronic hemodialysis They habitually consume less 16 oz milk per day get less 10 hour sun exposure per week . We exclude granulomatous condition , cirrhotic liver disease , take anticonvulsant , barbiturate , steroid form investigational drug within 4 week . We exclude pregnancy plan pregnancy , hypercalcemia ( &gt; 10.4 mg/dl ) previously record , chronic GI disease would interfere absorption , allergy vitamin D3 , chronic vitamin D intake &gt; 1,000 IU daily . Subjects continue take calcitriol analogue phosphorus binder prescribe nephrologist . Calcitriol analogues document remain constant throughout study .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>chronic kidney disease</keyword>
</DOC>